Inventor
POGUE SARAH L
US12 patents
⚠️ This page may combine multiple inventors who share the name “POGUE SARAH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
7 patentsUS10232041B2Mar 19, 2019
Combination of lenalidomide and polypeptide construct, and uses thereof
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD9 citations81
US9636334B2May 2, 2017
Combination of lenalidomide and polypeptide construct, and uses thereof
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD9 citations81
US9611322B2Apr 4, 2017
Fusions of antibodies to CD38 and attenuated interferon alpha
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD6 citations81
US10981986B2Apr 20, 2021
Fusions of antibodies to CD38 and attenuated interferon alpha
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD2 citations70
US9963515B2May 8, 2018
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD5 citations70
US11253591B2Feb 22, 2022
Combination of lenalidomide and polypeptide construct, and uses thereof
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD0 citations60
US11117975B2Sep 14, 2021
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD1 citations60
TERRETT JONATHAN A
3 patentsUS8268970B2Sep 18, 2012
Human antibodies that bind mesothelin, and uses thereof
TERRETT JONATHAN A65 citations96
US8399623B2Mar 19, 2013
Human antibodies that bind mesothelin, and uses thereof
TERRETT JONATHAN A25 citations91
US8425904B2Apr 23, 2013
Human antibodies that bind mesothelin, and uses thereof
TERRETT JONATHAN A9 citations82